Sputnik V Vaccine Found Efficacious When Stored in Standard Refrigerators

Kai Kupferschmidt, a correspondent for Science.org reported on November 24, 2020, 'the developers of the Sputnik V vaccine reported 91.4% efficacy from a second interim analysis of more than 18,000 people, bolstering a claim the team made on November 11th. Whereas the initial report rested on a mere 20 cases of COVID-19, with limited details, the new analysis is based on 39 cases total, eight among the vaccinated group versus 31 in the much smaller placebo arm.'

Another benefit of the Sputnik V vaccine is adenovirus vaccines is they can be stored in standard refrigerators, rather than needing cold-chain freezers.

Charlotte Houldcroft, a virologist at the University of Cambridge, added, “If the figures are as good as they appear, that’s really promising because this needs a standard cold chain to be rolled out rather than an ultracold chain like the RNA vaccines, and that’s a big plus.”